Biodesix, Inc.
BDSX
$0.4266
-$0.0198-4.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.47% | -12.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.47% | -12.10% | |||
| Cost of Revenue | 8.86% | -14.72% | |||
| Gross Profit | 12.15% | -11.39% | |||
| SG&A Expenses | 9.60% | 1.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.96% | 0.17% | |||
| Operating Income | -6.95% | -38.45% | |||
| Income Before Tax | -3.31% | -34.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.31% | -34.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.31% | -34.54% | |||
| EBIT | -6.95% | -38.45% | |||
| EBITDA | -8.32% | -49.56% | |||
| EPS Basic | -3.17% | -34.64% | |||
| Normalized Basic EPS | -3.83% | -35.45% | |||
| EPS Diluted | -3.17% | -34.64% | |||
| Normalized Diluted EPS | -3.83% | -35.45% | |||
| Average Basic Shares Outstanding | 0.07% | -0.04% | |||
| Average Diluted Shares Outstanding | 0.07% | -0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||